susana mato

Affiliations: 
Univ P Vasco, Leioa, Euskadi, Spain 
Google:
"susana mato"
Mean distance: 18.32 (cluster 32)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bernal-Chico A, Manterola A, Cipriani R, et al. (2020) P2x7 receptors control demyelination and inflammation in the cuprizone model. Brain, Behavior, & Immunity - Health. 4: 100062
Huerga-Gómez A, Aguado T, Sánchez-de la Torre A, et al. (2020) Δ -Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo. Glia
Canedo-Antelo M, Serrano MP, Manterola A, et al. (2018) Inhibition of Casein Kinase 2 Protects Oligodendrocytes From Excitotoxicity by Attenuating JNK/p53 Signaling Cascade. Frontiers in Molecular Neuroscience. 11: 333
Manterola A, Bernal-Chico A, Cipriani R, et al. (2018) Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis. Neuropharmacology
Mato S, Pilar-Cuéllar F, Valdizán EM, et al. (2018) Selective up-regulation of cannabinoid CB receptor coupling to Go-proteins in suicide victims with mood disorders. Biochemical Pharmacology
Manterola A, Bernal-Chico A, Cipriani R, et al. (2018) Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination. Biochemical Pharmacology
Gomis-González M, Matute C, Maldonado R, et al. (2016) Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model. Genes. 7
Borralleras C, Mato S, Amédée T, et al. (2016) Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams-Beuren syndrome. Molecular Brain. 9: 76
Bernal-Chico A, Canedo M, Manterola A, et al. (2015) Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo. Glia. 63: 163-76
Busquets-Garcia A, Gomis-González M, Guegan T, et al. (2013) Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nature Medicine. 19: 603-7
See more...